Investigating the genetic causal relationship between breast cancer and endometrial cancer: A two-sample Mendelian randomization study

Jian-Cong Wu,Xiao-Bi Huang,Yan-Ming Lin,Qi Zhang,Xiao-Rao Chen,Zhong Huang,Hai-Yin Ye,Yu-Liu Xie,Zhi-Xiong Yang,Wen-Mei Su,Qi-Biao Wu
DOI: https://doi.org/10.1097/md.0000000000040153
IF: 1.6
2024-10-30
Medicine
Abstract:Due to lifestyle changes and societal developments, a significant shift in the spectrum of human tumor diseases has occurred. [ 1 , 2 ] According to recent data from the American Cancer Society, breast cancer (BC) has emerged as the most prevalent malignant tumor, with an estimated 297,790 new cases reported in 2023, constituting approximately one-third of all female malignancies. [ 3 ] Significant variations are observed among various countries and regions, yet, an overall upward trend is noticeable. [ 4 ] Despite the rising incidence, the mortality rate of BC has declined, attributable to advancements in early diagnosis and treatment. [ 5 ] With the extension of patient survival periods, there is an increasing focus on concerns such as the long-term side effects of antitumor treatments and the emergence of secondary primary malignancies.
medicine, general & internal
What problem does this paper attempt to address?